Votre Partenaire en Modélisation & Simulation Pharmacocinétique !

PhinC met en place la meilleure stratégie de Modélisation & Simulation pour orienter les étapes clefs de votre développement et optimiser ses coûts.
Les services PhinC
Nos actualités

Ils nous font confiance

Antoine Tarral
Antoine Tarral
Head of HAT Clinical Programme - DNDi
The PhinC Development team has accompanied us throughout this program. In particular, their expertise in pharmacokinetic modeling has enabled us to select the therapeutic dose and optimize the dose regimen. I most particularly appreciated their continuous involvement, their professionalism and their ability to work together with all the other actors involved in this program.
Pascal Benderitter
Pascal Benderitter
Senior Program Director NCX - Oncodesign Precision Medicine
In the frame of the preclinical development of our main asset, we have been looking after experts in the modeling of pharmacokinetics. Working with PhinC, a member of the AFFSSI, has only seemed natural in regards with their recognized expertise and by a common vision of long-term collaboration. Their work on a PBPK model was a clear added value in the regulatory filing and contributed to the approval of the clinical trial application early 2023. We are happy to count them among the key players in the ongoing clinical study on ODS-101.
Agnes Hemon
Agnes Hemon
Preclinical and PK Clinical Officer - HRA Pharma
PhinC is one of HRA Pharma’s valuable partners for pharmacokinetic studies. From just advice to modeling, we know we can trust them to efficiently support and carry out our projects.
Olivier Lacombe
Olivier Lacombe
Head of Pharmacokinetics - Inventiva
Inventiva and PhinC have been collaborating for several years on popPK and PBPK modeling activities. The decision to work with PhinC was based on the team expertise in pharmacokinetics and modeling within drug development, and their aptitude to react and to collaborate within a biotech context. Moreover their approach is based on the client listening and project understanding in order to propose the most adequate proposal to the request. Our relationship is very pleasant, efficient and fruitful for both the scientific and project outputs.
Club Phase 1
GMP - Groupe de Métabolisme et Pharmacocinétique
EUFEMED
AFSSI
MabDesign
Oncodesign services
Paris Saclay
France Biotech
Paris Region Business Club
Medicen
French Tech Paris-Saclay
Genopole